Matinas BioPharma(MTNB) - 2022 Q1 - Earnings Call Transcript

Matinas BioPharma Holdings Inc. (NYSE:MTNB) Q1 2022 Earnings Conference Call May 12, 2022 8:30 AM ET Company Participants Jerome Jabbour - Chief Executive Officer Theresa Matkovits - Chief Development Officer Terry Ferguson - Chief Medical Officer Keith Kucinski - Chief Financial Officer Peter Vozzo - Investor Relations Conference Call Participants Bert Hazlett - BTIG Operator Welcome to the Matinas BioPharma First Quarter 2022 Results Conference Call. At this time, all participants are in a listen-only m ...